Contact us

Contact your dedicated technical advisor for individual case based support 

Acknowledgements

Dechra would like to thank Ian Ramsey BVSc, PhD, DSAM, DipECVIM-CA, FHEA, FRCVS and Emma Roberts BVetMed (Hons) MVM DipECVIM-CA, MRCVS, EBVS, for their original Dechra content which has been adapted in the creation of this page.


References

  • Baumstark, M.E et al (2014) Use of plasma renin activity to monitor mineralocorticoid treatment in dogs with primary hypoadrenocorticism: desoxycorticosterone versus fludrocortisone. Journal of Veterinary Internal Medicine 28(5), 1471-8
  • CVMP Assessment report for Zycortal (EMEA/V/C/003782/0000) 2015 pg 19
  • Lockart-Mason, B. and Farr, H (2015) Internal report ZYC2015001: A comparison of the efficacy and safety of desoxycortone pivalate (Zycortal Suspension for Injection™) for the treatment of primary hypoadrenocorticism in client-owned dogs previously treated with fludrocortisone acetate and in newly diagnosed cases
  • Melián, C & Peterson, M. E (1996) Diagnosis and treatment of naturally occurring hypoadrenocorticism in 42 dogs The Journal of Small Animal Practice 37(6), 268–275
  • ·Niessen, S et al (2021) European Society of Veterinary Endocrinology, Accessed 11th April 2023 https://www.esve.org/alive/search.aspx
  • Peterson, M. E, Kintzer, P. P & Kass, P. H (1996) Pretreatment clinical and laboratory findings in dogs with hypoadrenocorticism: 225 cases (1979-1993) Journal of the American Veterinary Medical Association 208(1), 85–91
  • Ramsey, I.K & Herrtage, M,E (2015) Adrenal gland diseases, BSAVA Manual of Small Animal Clinical Pathology (3rd Edition) Ed Villers E.J. & Ristic J.A. BSAVA publications, Gloucester
  • Scott-Moncrieff, J. C. (2015) Hypoadrenocorticism. In Canine and Feline Endocrinology. Eds E. C. Feldman, R. W. Nelson, C. E. Reusch, J. C. Scott-Moncrieff, E. N. Behrend. Elsevier. 485-520
keyboard_arrow_up